TXMD

Therapeuticsmd Inc

2.110

+0.060+2.93%

After Hours: 2.110 0.000 0.00%16:10 04/14 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.030/2.050

TODAY RANGE2.030-2.220

VOL59.72K

MARKET CAP24.42M

52 WEEK RANGE0.9252-2.950

AVG VOL (3M)48.24K

% TURNOVER0.52%

TURNOVER--

P/E (TTM)-42.8862

% RANGE9.27%

EPS(TTM)-0.0492

P/E(FORWARD)13.19

P/B0.9087

BVPS2.322

DIVIDEND--

P/S8.08

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP22.60M

SHARES OUTSTANDING11.57M

NEXT EARNINGS05/11-05/15

FREE FLOAT10.71M

LOT SIZE1

EX-DATE05/09/2022

News

Press Releases

Financial Reports

Profile

Dow Jones·04/06 20:32
TherapeuticsMD Inc. Stock Rallies 10.0%, Outperforms Market
TipRanks·04/01 15:39
TherapeuticsMD Explains Brief Delay In Annual Filing
Reuters·04/01 10:08
TherapeuticsMD delays 2025 10-K after filing omits auditor report
TipRanks·03/31 00:12
TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy
Dow Jones·03/30 20:34
TherapeuticsMD Inc. Stock Slides 5.2%, Underperforms Market
TipRanks·03/30 20:23
TherapeuticsMD reports FY25 EPS (6c) vs. (20c) last year
Seeking Alpha·03/30 20:15
Therapeutics MD reports FY results
Dow Jones·03/30 20:12
*TherapeuticsMD Has Not Established a Timetable for Completion of This Exploration Process >TXMD
Dow Jones·03/30 20:12
*TherapeuticsMD Won't Disclose Further Developments Unless and Until Determined Disclosure Is Appropriate or Necessary >TXMD
Dow Jones·03/30 20:11
*TherapeuticsMD Continues to Evaluate a Variety of Strategic Alternatives >TXMD
Reuters·03/30 20:07
TherapeuticsMD FY25 net loss from continuing operations narrows 73.91% to $0.7 million
Reuters·03/30 20:05
THERAPEUTICSMD ANNOUNCES FULL YEAR 2025 FINANCIAL RESULTS
Dow Jones·03/30 20:05
Press Release: TherapeuticsMD Announces Full Year 2025 Financial Results
Dow Jones·03/13 20:32
TherapeuticsMD Inc. Stock Sheds 4.8%, Underperforms Market
Dow Jones·02/09 21:33
TherapeuticsMD Inc. Stock Climbs 8.3%, Outperforms Market

Same Industry

Name/Symbol

Change%

Price

TXMD

MCK

BIIB

Amgen Inc

AMGN

-1.29%

351.02

SHPG

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-9.29%

0.0898

Celgene

CELG

0.00%

108.24

LLY

Johnson & Johnson

JNJ

-1.18%

238.46

Abbvie Inc

ABBV

-2.10%

207.94

ZTS

Gilead Sciences Inc

GILD

-2.18%

138.99

Novo-Nordisk A/S

NVO

+0.21%

37.52

Bristol-Myers Squibb Co

BMY

-1.43%

58.62

Alexion Pharms

ALXN

0.00%

182.50

PFE

Sanofi FR

SNY

-0.68%

46.76

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-0.65%

154.05

Dr Reddys Labs

RDY

+0.38%

13.31

GSK

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.